Title : Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas.

Pub. Date : 2010 Apr 15

PMID : 19626585






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
2 Overexpression of ERCC1 mRNA is associated with drug resistance to cisplatin in human gliomas, but the role of the ERCC1 promoter in drug resistance has not been demonstrated. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
3 We have used sodium bisulfite sequencing to compare ERCC1 promoter methylation patterns in cisplatin-sensitive and cisplatin-resistant glioma cells. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
4 Hypermethylation was observed in the upstream 5Kb region of the ERCC1 promoter of cisplatin-sensitive glioma cell lines. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
5 ERCC1 DNA methylation levels were highly variable in 32 human glioma samples ranging from 0.1 to 0.87, which have shown significant difference between cisplatin-sensitive samples and cisplatin-resistant samples (p < 0.05). Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
6 ERCC1 DNA methylation levels were highly variable in 32 human glioma samples ranging from 0.1 to 0.87, which have shown significant difference between cisplatin-sensitive samples and cisplatin-resistant samples (p < 0.05). Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
7 ERCC1 DNA methylation could regulate the expression of downstream mRNA and protein, and was associated with cisplatin chemosensitivity. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens